Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies

NCT04418661 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

65

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision not related to any safety concern

Conditions

Metastatic Neoplasm

Interventions

DRUG: Vociprotafib
DRUG: Pembrolizumab
DRUG: Adagrasib

Sponsor

Sanofi

Collaborators

[object Object]
[object Object]